Home / Facilities / 3005144056

Piedmont Reproductive Endocrinology Group, Pa FDA Inspection Record

FEI 3005144056 · Inspections, Form 483s, warning letters and import refusals

Piedmont Reproductive Endocrinology Group, Pa is an FDA-inspected facility (FEI 3005144056) located in Greenville, SC, US. RegDataLab tracks 7 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Jan 21, 2026: Voluntary Action Indicated (VAI)
Inspections on record
7 (1 VAI, 6 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jan 21, 2026Voluntary Action Indicated (VAI)Abbreviated procedure (21 CFR 1271.75(e))
Dec 6, 2022No Action Indicated (NAI)No citations listed
Jan 28, 2020No Action Indicated (NAI)No citations listed
Jan 31, 2018No Action Indicated (NAI)No citations listed
Apr 19, 2016No Action Indicated (NAI)No citations listed
Apr 29, 2014No Action Indicated (NAI)No citations listed
May 25, 2010No Action Indicated (NAI)No citations listed

FDA record score

6 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 15, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

1 record behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIJan 21, 20266 x 16

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 15, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 15, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 14, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 15, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Piedmont Reproductive Endocrinology Group, Pa as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Piedmont Reproductive Endocrinology Group, Pa yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Piedmont Reproductive Endocrinology Group, Pa
Location
Greenville, SC (US)
Source
inspections

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.